by michaelhalassa | Jul 16, 2025 | Cobenfy, Algorithmic psychiatry, Computational psychiatry, Distributed neural systems, Dopamine and psychosis, KarXT, Mental health treatment, Michael Halassa, muscarinic antipsychotic, Schizophrenia treatment, Xanomeline
I had the privilege of attending and in part organizing the inaugural Innovation in Psychosis Therapeutics Summit in Boston (June 9-11, 2025). This intimate gathering brought together scientists, clinicians and biotech leaders who share a common goal: to finally push...
by michaelhalassa | Jul 11, 2025 | Algorithmic psychiatry, Healthcare, Mental health treatment, muscarinic antipsychotic, Schizophrenia treatment
The recent Innovation in Psychosis Therapeutics Summit in Boston revealed a clear truth: while the field celebrates breakthroughs like muscarinic agents, it’s equally clear that psychiatric drug development needs a neuroscience reboot. We’ve mastered...
by michaelhalassa | Jul 10, 2025 | Computational psychiatry, Executive Control, Michael Halassa, Reinforcement learning, Schizophrenia
As a psychiatrist who treats patients with schizophrenia, I’ve long been struck by a fundamental puzzle: why do individuals with psychosis hold onto beliefs with such unwavering certainty, even when presented with compelling contradictory evidence? The answer,...
